Arrhythmogenic Right Ventricular Dysplasia

What is Arrhythmogenic Right Ventricular Dysplasia?

Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic

right ventricular cardiomyopathy (ARVC), is an inherited heart condition that affects

the muscle tissue of the heart's right ventricle, leading to abnormal heart rhythms

and potential complications like sudden cardiac arrest.

It can be diagnosed through various tests, and treatment usually entails managing

symptoms through lifestyle changes, medications, and sometimes the implantation of

a cardioverter-defibrillator. Early diagnosis and management are essential for

effectively preventing arrhythmogenic right ventricular dysplasia.

Types of Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia (ARVD) can be categorized into two major

types based on the heart muscle's involvement pattern.

  • Fat-predominant ARVD: This form has more fatty infiltration of the heart

    muscle that may be visible in imaging studies.

  • Fibrofatty ARVD: This condition is defined by a combination of fibrosis and

    fatty infiltration in the heart muscle.

    It should be noted that these two types ARVD symptoms are not always distinct;

    they may overlap.


Arrhythmogenic right ventricular dysplasia (ARVD) can be identified with various
symptoms, and some people may even have no signs at all. But the most common
signs associated with ARVD include: 

  • Palpitations
  • A feeling of skipped beats
  • Fluttering or racing heart
  • Shortness of breath, particularly during exercise or physical activity
  • Fainting or dizziness
  • Swelling in the legs or ankles
  • Chest pain
  • Sudden cardiac arrest in rare cases It is essential to remember that not all palpitations or chest pain are related to ARVD, and many people with the condition may not exhibit any symptoms until later in life.


Arrhythmogenic right ventricular dysplasia (ARVD) remains uncertain, but it is considered an inherited disorder. ARVD is often caused by mutations in genes responsible for producing proteins found in the heart muscle. However, its exact
cause remains a mystery.
Genetic mutations can cause the replacement of normal heart muscle with fatty and
fibrous tissue, disrupting electrical signals that control heartbeat rhythm, leading to
irregular heart rhythms and potential risks such as sudden cardiac arrest.
ARVD is typically inherited in an autosomal dominant pattern, meaning a person only needs one copy of the mutated gene from one parent to develop ARVD heart
condition. However, people without any family history of ARVD can develop it
through new genetic mutations or other unknown causes.
Though genetic mutations cannot be reversed, early diagnosis and management of
ARVD can reduce the risk of complications and improve outcomes. If your family
history includes ARVD or you are experiencing symptoms associated with the
condition, there may be high risks in ARVD.

Risk Factors

Age: ARVD can affect people of any age but is most frequently diagnosed in
those between 20 and 50.

  • Gender: Men are statistically more likely to develop ARVD than women.
  • Exercise: Prolonged and intense physical activity, especially endurance
    sports, may increase the risks in ARVD; however, its exact relationship is
    complex and still being explored.
  • Other Cardiovascular Conditions: People with other heart issues, such as
    cardiomyopathy or heart failure, may be at a greater risk for developing
    It is essential to remember that having one or more of these risk factors does not guarantee someone will develop ARVD; many individuals with the condition have no ARVD symptoms.

Prevent Arrhythmogenic Right Ventricular Dysplasia

Some steps can be taken to reduce the likelihood of complications and enhance
outcomes for people living with ARVD:

  • Regular Check-Ups: If your family history of ARVD or you have been
    diagnosed with the condition, it is essential to have regular check-ups with
    your cardiologist to monitor and attain proper arrhythmogenic right
    ventricular dysplasia treatment.
  • Medications: Some medications, such as beta-blockers, anti-arrhythmic
    drugs, and blood thinners, may be used to manage symptoms and lower the
    risk of complications.
  • Lifestyle Modifications: Avoiding or reducing intense physical activity, particularly endurance sports, can help reduce the risk of complications and worsen the condition. Maintaining a healthy weight and abstaining from tobacco use is also beneficial.
  • Installable Cardioverter-defibrillator (ICD): For those at higher risk for sudden cardiac arrest, an ICD may be implanted to detect and treat life-threatening arrhythmias.

It is essential to recognize that managing ARVD can be a complex issue requiring
the expertise of multiple healthcare professionals, such as cardiologists, genetic
counsellors, and others.


Here is a general outline of the stages of ARVD:

  • Early Stage: In the early stages, individuals may only experience mild ARVD
    symptoms or none. On imaging tests, they may have abnormal
    electrocardiogram (ECG) findings or signs of structural changes to the right
    ventricle, but no significant damage has yet occurred to the heart muscle.
  • Moderate Stage: As the condition progresses, individuals may experience
    more noticeable ARVD symptoms like palpitations, shortness of breath, and
    exercise intolerance. Imaging tests may reveal evidence of progressive right
    ventricular dysfunction, such as decreased contractility or enlargement in the
    right ventricle.
  • Advanced Stage: At this stage of ARVD, individuals may have substantial
    muscle damage that leads to heart failure and arrhythmias, with an increased
    risk for sudden cardiac death. In severe cases, they may require more
    aggressive treatments such as medications, implantable cardioverter-
    defibrillators (ICDs), or even heart transplants.
    It is important to remember that the progression of ARVD can vary between
    individuals, and some may never progress past the early stages.


Here are some standard methods used for ARVD diagnosis:



Here are some critical points on the treatment and management of Arrhythmogenic

Right Ventricular Dysplasia (ARVD):


  • Medications

    Medications such as beta-blockers and anti-arrhythmic drugs may be
    prescribed to regulate heart rhythm in individuals with ARVD.

  • Lifestyle modifications

    Lifestyle modifications, such as avoiding vigorous exercise and sports, may
    be recommended to reduce the risk of sudden cardiac arrest.

  • Implantable cardioverter-defibrillators

    Implantable cardioverter-defibrillators (ICDs) can detect and correct
    dangerous heart rhythms by administering an electrical shock directly into the

  • Comprehensive care

    Patients with ARVD should receive comprehensive care from a team of
    specialists, including cardiologists, electrophysiologists, and genetic

  • Genetic testing

    Genetic testing may be recommended for patients with ARVD and their family
    members to detect any underlying genetic mutations that could increase the
    likelihood of developing the condition.

  • Transplantation

    In some cases, heart transplantation may be necessary for patients with
    severe heart failure who have failed to respond to other treatments.

    The management of ARVD requires a personalized approach based on the
    conditions severity, symptoms present, and potential complications.

Road to Recovery and Aftercare

Arrhythmogenic Right Ventricular Dysplasia (ARVD) requires lifelong monitoring,

lifestyle modifications, and medication adjustments. Once an initial diagnosis and

treatment are made, patients with ARVD must continue worki..

  • Have a question?

    Call us +91 - 124 - 4141414